- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- January 2026
- 185 Pages
Global
From €4036EUR$4,500USD£3,486GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,549GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1345EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,162GBP
- Report
- January 2026
- 180 Pages
Global
From €4036EUR$4,500USD£3,486GBP
- Report
- June 2025
- 150 Pages
Global
From €2421EUR$2,699USD£2,091GBP
- Report
- June 2025
- 200 Pages
Global
From €2502EUR$2,789USD£2,160GBP
- Report
- August 2025
- 150 Pages
Global
From €3453EUR$3,850USD£2,982GBP
€4350EUR$4,850USD£3,757GBP
- Report
- July 2025
- 150 Pages
Global
From €3453EUR$3,850USD£2,982GBP
€4350EUR$4,850USD£3,757GBP
- Report
- May 2025
- 134 Pages
Global
From €16141EUR$17,995USD£13,940GBP
- Report
- August 2025
- 98 Pages
Global
From €4350EUR$4,850USD£3,757GBP
- Report
- March 2026
- 50 Pages
Global
From €2377EUR$2,650USD£2,053GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more